Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 423,137 | 465,212 | 421,268 | 572,336 | 491,704 |
| General And Administrative Expense | 423,137 | 465,212 | 421,268 | 572,336 | 491,704 |
| Depreciation And Amortization In Income Statement | 1,812 | 1,592 | 1,580 | 1,593 | 1,592 |
| Other Operating Expenses | 1.2M | 346,862 | 342,011 | 884,374 | 2.6M |
| Operating Expense | 1.6M | 813,666 | 764,859 | 1.5M | 3.1M |
| Operating Income | -1.6M | -813,666 | -764,859 | -1.5M | -3.1M |
| EBIT | -1.6M | -813,666 | -764,859 | -1.5M | -3.1M |
| Interest Income | 14,681 | 47.00 | 2,587 | 22,457 | 38,629 |
| Interest Income Non Operating | 14,681 | 47.00 | 2,587 | 22,457 | 38,629 |
| Net Interest Income | 14,681 | 47.00 | 2,587 | 22,457 | 38,629 |
| Other Income Expense | -422.00 | -2,065 | 21,534 | 55,343 | -17,508 |
| Special Income Charges | -- | -- | -- | 0.00 | 0.00 |
| Gain On Sale Of Security | -422.00 | -2,065 | 21,534 | 55,343 | -17,508 |
| Pretax Income | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Net Income From Continuing Operation Net Minority Interest | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Net Income Including Noncontrolling Interests | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Net Income Common Stockholders | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Net Income | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| EBITDA | -1.6M | -812,074 | -763,279 | -1.5M | -3.1M |
| Normalized EBITDA | -1.6M | -810,009 | -784,813 | -1.5M | -3.1M |
| Reconciled Depreciation | 1,812 | 1,592 | 1,580 | 1,592 | 1,592 |
| Basic EPS | -0.03 | -0.02 | -0.02 | -- | -0.07 |
| Diluted EPS | -0.03 | -0.02 | -0.02 | -- | -0.07 |
| Basic Average Shares | 52.6M | 47.4M | 45.4M | -- | 43.9M |
| Diluted Average Shares | 52.6M | 47.4M | 45.4M | -- | 43.9M |
| Total Unusual Items | -422.00 | -2,065 | 21,534 | 55,343 | -17,508 |
| Total Unusual Items Excluding Goodwill | -422.00 | -2,065 | 21,534 | 55,343 | -17,508 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.6M | -813,619 | -762,272 | -1.4M | -3.1M |
| Depreciation Amortization Depletion Income Statement | 1,812 | 1,592 | 1,580 | 1,593 | 1,592 |
| Depreciation Income Statement | 1,812 | 1,592 | 1,580 | 1,593 | 1,592 |
| Diluted NI Availto Com Stockholders | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 | 0.00 |
| Net Income Continuous Operations | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Net Non Operating Interest Income Expense | 14,681 | 47.00 | 2,587 | 22,457 | 38,629 |
| Other Gand A | 297,616 | 317,393 | 275,146 | 228,463 | 259,519 |
| Salaries And Wages | 125,521 | 147,819 | 146,122 | 343,873 | 232,185 |
| Total Expenses | 1.6M | 813,666 | 764,859 | 1.5M | 3.1M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.5M | 3.2M | 465,199 | 990,599 | 2.5M |
| Cash Cash Equivalents And Short Term Investments | 1.5M | 3.2M | 465,199 | 990,599 | 2.5M |
| Cash Financial | -- | 3.2M | 465,199 | 990,599 | 2.5M |
| Receivables | 20,437 | 15,509 | -- | 0.00 | 1,001 |
| Prepaid Assets | 71,898 | 77,320 | 70,004 | 100,905 | 95,476 |
| Current Assets | 1.6M | 3.3M | 535,203 | 1.1M | 2.6M |
| Gross PPE | 8.3M | 8.3M | 8.3M | 8.3M | 8.3M |
| Accumulated Depreciation | -317,948 | -316,136 | -314,544 | -312,964 | -311,371 |
| Net PPE | 8.0M | 7.9M | 7.9M | 8.0M | 8.0M |
| Other Non Current Assets | 610,950 | 610,950 | 610,950 | 610,950 | 610,950 |
| Total Non Current Assets | 8.6M | 8.6M | 8.6M | 8.6M | 8.6M |
| Total Assets | 10.2M | 11.9M | 9.1M | 9.7M | 11.2M |
| Accounts Payable | 249,372 | 296,656 | 231,330 | 125,085 | 353,315 |
| Payables | 310,879 | 358,163 | 671,426 | 125,085 | 353,315 |
| Payables And Accrued Expenses | 311,056 | 358,617 | 684,727 | 125,526 | 353,915 |
| Current Accrued Expenses | 177.00 | 454.00 | 13,301 | 441.00 | 600.00 |
| Current Liabilities | 311,056 | 358,617 | 684,727 | 125,526 | 353,915 |
| Total Non Current Liabilities Net Minority Interest | 1.1M | 1.0M | 601,891 | 1.0M | 1.1M |
| Total Liabilities Net Minority Interest | 1.4M | 1.4M | 1.3M | 1.2M | 1.4M |
| Common Stock | 55.3M | 55.3M | 52.7M | 52.7M | 52.7M |
| Capital Stock | 55.3M | 55.3M | 52.7M | 52.7M | 52.7M |
| Additional Paid In Capital | 22.5M | 22.5M | 21.7M | 21.6M | 21.3M |
| Retained Earnings | -68.8M | -67.2M | -66.4M | -65.6M | -64.2M |
| Gains Losses Not Affecting Retained Earnings | -204,553 | -157,886 | -182,753 | -185,509 | -88,693 |
| Other Equity Adjustments | -204,553 | -157,886 | -182,753 | -185,509 | -88,693 |
| Common Stock Equity | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Stockholders Equity | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Total Equity Gross Minority Interest | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Total Capitalization | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Net Tangible Assets | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Tangible Book Value | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Working Capital | 1.3M | 2.9M | -149,524 | 965,978 | 2.2M |
| Invested Capital | 8.8M | 10.4M | 7.8M | 8.5M | 9.7M |
| Share Issued | 52.6M | 52.6M | 45.4M | 45.4M | 45.4M |
| Ordinary Shares Number | 52.6M | 52.6M | 45.4M | 45.4M | 45.4M |
| Dueto Related Parties Current | 61,507 | 61,507 | 440,096 | -- | -- |
| Dueto Related Parties Non Current | 440,095 | 440,095 | 0.00 | 440,095 | 440,095 |
| Long Term Provisions | 614,567 | 608,229 | 601,891 | 595,553 | 636,515 |
| Non Current Prepaid Assets | 7,107 | 7,107 | 7,107 | 7,107 | 7,107 |
| Other Properties | 8.3M | 8.3M | 8.3M | 8.3M | 8.3M |
| Other Receivables | 20,437 | -- | -- | -- | 1,001 |
| Taxes Receivable | -- | 15,509 | -- | -- | -- |
| Tradeand Other Payables Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.6M | -718,760 | -526,880 | -1.5M | -2.6M |
| Cash Flow From Continuing Operating Activities | -1.6M | -718,760 | -526,880 | -1.5M | -2.6M |
| Depreciation And Amortization | 1,812 | 1,592 | 1,580 | 1,592 | 1,592 |
| Depreciation Amortization Depletion | 1,812 | 1,592 | 1,580 | 1,592 | 1,592 |
| Stock Based Compensation | 35,255 | 57,275 | 54,657 | 253,784 | 141,867 |
| Change In Working Capital | -47,067 | 29,654 | 150,006 | -233,818 | 314,987 |
| Change In Receivables | -4,928 | -- | -- | -- | -- |
| Change In Payables And Accrued Expense | -47,561 | 52,479 | 119,105 | -228,389 | 306,090 |
| Change In Payable | -47,561 | 52,479 | 119,105 | -- | 306,090 |
| Other Non Cash Items | 6,338 | 6,338 | 6,338 | -- | -- |
| Net PPE Purchase And Sale | -- | -- | -- | 0.00 | 0.00 |
| Investing Cash Flow | -- | -- | -- | 0.00 | 0.00 |
| Cash Flow From Continuing Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Issuance Of Capital Stock | 0.00 | 3.4M | 0.00 | -13,773 | 1.2M |
| Net Common Stock Issuance | 0.00 | 3.4M | 0.00 | -13,773 | 1.2M |
| Financing Cash Flow | 0.00 | 3.4M | 0.00 | -13,773 | 1.2M |
| Cash Flow From Continuing Financing Activities | 0.00 | 3.4M | 0.00 | -13,773 | 1.2M |
| Effect Of Exchange Rate Changes | -47,088 | 22,801 | 1,480 | -- | 0.00 |
| Changes In Cash | -1.6M | 2.7M | -526,880 | -1.5M | -1.4M |
| Beginning Cash Position | 3.8M | 1.1M | 1.6M | 3.1M | 4.5M |
| End Cash Position | 2.1M | 3.8M | 1.1M | 1.6M | 3.1M |
| Free Cash Flow | -1.6M | -718,760 | -526,880 | -1.5M | -2.6M |
| Change In Account Payable | -- | 52,479 | 119,105 | -- | -- |
| Change In Prepaid Assets | 5,422 | -7,316 | 30,901 | -5,429 | 8,897 |
| Common Stock Issuance | 0.00 | 3.4M | 0.00 | -13,773 | 1.2M |
| Depreciation | 1,812 | 1,592 | 1,580 | 1,592 | 1,592 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 421.00 | 2,065 | 1,277 | -95,814 | 14,712 |
| Net Income From Continuing Operations | -1.6M | -815,684 | -740,738 | -1.4M | -3.1M |
| Net Other Financing Charges | 0.00 | -- | -- | -- | -- |
| Operating Gains Losses | 421.00 | 2,065 | 1,277 | -95,814 | 14,712 |
| Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |